Cognetivity Neurosciences
€0
0
+€0+0% Thursday 06:00
統計
當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
604,755
市盈率
-
股息收益率
-
股息
-
收益
16Dec預期
預期每股收益
N/A
實際每股收益
-0.017
人們還關注
此列表基於在 Stock Events 上關注 1UB.F 的人的關注列表。這不是投資建議。
競爭者
這個列表是基於最近市場事件的分析。這不是投資建議。
Lilly(Eli) &
LLY
市值864.43B
Biogen
BIIB
市值29.83B
Pfizer
PFE
市值164.39B
Merck
MRK
市值300.25B
Abbott Laboratories
ABT
市值197.08B
Sage Therapeutics
SAGE
市值514.65M
Novartis
NVS
市值244.75B
Johnson & Johnson
JNJ
市值399.26B
AC Immune SA
ACIU
市值319.58M
關於
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Show more...
首席執行官
Dr. Sina Habibi
國家
CA
ISIN
CA19243C1005
WKN
000A2JGJZ